GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Asensus Surgical Inc (FRA:2TX) » Definitions » Forward PE Ratio

Asensus Surgical (FRA:2TX) Forward PE Ratio : 0.00 (As of May. 21, 2024)


View and export this data going back to 2016. Start your Free Trial

What is Asensus Surgical Forward PE Ratio?

Asensus Surgical's Forward PE Ratio for today is 0.00.

Asensus Surgical's PE Ratio without NRI for today is 0.00.

Asensus Surgical's PE Ratio for today is 0.00.


Asensus Surgical Forward PE Ratio Historical Data

The historical data trend for Asensus Surgical's Forward PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Asensus Surgical Forward PE Ratio Chart

Asensus Surgical Annual Data
Trend
Forward PE Ratio

Asensus Surgical Quarterly Data
Forward PE Ratio

Competitive Comparison of Asensus Surgical's Forward PE Ratio

For the Medical Devices subindustry, Asensus Surgical's Forward PE Ratio, along with its competitors' market caps and Forward PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Asensus Surgical's Forward PE Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Asensus Surgical's Forward PE Ratio distribution charts can be found below:

* The bar in red indicates where Asensus Surgical's Forward PE Ratio falls into.



Asensus Surgical Forward PE Ratio Calculation

It's a measure of the price-to-earnings ratio (PE Ratio) using forecasted earnings for the calculation. While the earnings used are just an estimate and are not as reliable as current earnings data, there is still benefit in estimated P/E analysis. The forecasted earnings used in the formula can either be for the next 12 months or for the next full-year fiscal period.


Asensus Surgical  (FRA:2TX) Forward PE Ratio Explanation

The Forward PE Ratio of a company is often used to compare current earnings to estimated future earnings, as well as gaining a clearer picture of what earnings will look like without charges and other accounting adjustments. If earnings are expected to grow in the future, the Forward PE Ratio will be lower than the current PE Ratio. This measure is also used to compare one company to another with a forward-looking focus.

Trailing PE Ratio relies on what is already done. It uses the current share price and divides by the total EPS (Basic) over the past 12 months. PE Ratio can be affected by Non Operating Income such as the sale of part of businesses. This may increase for the current year or quarter dramatically. But it cannot be repeated over and over. Therefore PE Ratio without NRI is a more accurate indication of valuation than PE Ratio .


Asensus Surgical Forward PE Ratio Related Terms

Thank you for viewing the detailed overview of Asensus Surgical's Forward PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Asensus Surgical (FRA:2TX) Business Description

Traded in Other Exchanges
Address
1 TW Alexander Drive, Suite 160, Durham, NC, USA, 27703
Asensus Surgical Inc is a medical device company that digitizes the interface between the surgeon and the patient to improve minimally invasive surgery through digital laparoscopy. It enables the use of advanced capabilities such as augmented intelligence, connectivity, and robotics in laparoscopy and seeks to address the current clinical, cognitive, and economic shortcomings in surgery. The Senhance Surgical System is the first machine vision system for use in robotic surgery, which is powered by the new Intelligent Surgical Unit that enables augmented intelligence in surgery and brings the benefits of digital laparoscopy to patients around the world. The company's single segment includes the research, development, and sale of medical device robotics to improve minimally invasive surgery.

Asensus Surgical (FRA:2TX) Headlines

No Headlines